Compounds > 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol
Page last updated: 2024-08-26

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Experimental Hepatoma

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bengmark, S; Persson, BG; Wang, LQ1

Other Studies

1 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Experimental Hepatoma

ArticleYear
Bioreduction of RSU 1069 and mitomycin C after dearterialization.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1993, Volume: 19, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Chemotherapy, Adjuvant; Hepatic Artery; Humans; Ligation; Liver Neoplasms, Experimental; Male; Misonidazole; Mitomycin; Rats; Rats, Inbred WF

1993